79P - Tissue microarray analysis on prognostic value of coexpression of RUNX3 and trimethylated histone H3 lysine 27 in surgically resected patients with stage I non-small cell lung cancer
Authors
- X. Chen (Fuzhou, China)
- Y. Deng (Fuzhou, China)
- Y. Shi (Fuzhou, China)
Speakers
- X. Chen (Fuzhou, China)
Advanced NSCLC
No ePoster preview available
173P - Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival
Authors
- S. Kroeze (Zurich, Switzerland)
- C. Fritz (Zurich, Switzerland)
- D. Kaul (Berlin, Germany)
- O. Blanck (Gustow, Germany)
- K. Kahl (Augsburg, Germany)
- F. Roeder (München, Germany)
- S. Siva (Melbourne, Australia)
- J. Verhoeff (Utrecht, Netherlands)
- A. Grosu (Freiburg, Germany)
- M. Schymalla (Marburg, Germany)
- M. Glatzer (St. Gallen, Switzerland)
- M. Szuecs (Rostock, Germany)
- M. Geier (Linz, Austria)
- G. Skazikis (Villingen-Schwenningen, Germany)
- I. Sackerer (Freising, Germany)
- F. Lohaus (Dresden, Germany)
- F. Eckert (Tübingen, Germany)
- M. Guckenberger (Zürich, Switzerland)
Speakers
- S. Kroeze (Zurich, Switzerland)
131P - Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
Authors
- C. Li (Shanghai, China)
- J. Guo (Shanghai, China)
- L. Zhao (Shanghai, China)
- F. Hu (Shanghai, China)
- W. Nie (Shanghai, China)
- H. Wang (Shanghai, China)
- X. Zheng (Shanghai, China)
- Y. Shen (Shanghai, China)
- P. Gu (Shanghai, China)
- Y. Zhang (Shanghai, China)
- X. Zhang (Shanghai, China)
Speakers
- C. Li (Shanghai, China)
190P - ERGR-TKIs combined with chemotherapy delays intracranial progression in EGFR-mutant lung adenocarcinoma patients
Authors
- C. Li (Shanghai, China)
- B. Zhang (Shanghai, China)
- J. Guo (Shanghai, China)
- F. Hu (Shanghai, China)
- W. Nie (Shanghai, China)
- X. Zheng (Shanghai, China)
- Y. Lou (Shanghai, China)
- Y. Shen (Shanghai, China)
- X. Zhang (Shanghai, China)
Speakers
- C. Li (Shanghai, China)
35P - Clinicopathological characteristics with genetic profiling and prognostic analysis of primary lymphoepithelioma-like carcinoma in Chinese south-eastern population
Authors
- Y. Shen (Shanghai, China)
- F. Hu (Shanghai, China)
- B. Zhang (Shanghai, China)
- B. Han (Shanghai, China)
Speakers
- Y. Shen (Shanghai, China)
153P - Chemotherapy with immune-checkpoint inhibitors in first-line treatment metastatic NSCLC patients: Systematic review and literature-based meta-analysis
Authors
- A. Addeo (Geneva, Switzerland)
- G. Banna (Catania, Italy)
- G. Metro (Perugia, (PG), Italy)
- M. Di Maio (Torino, Italy)
Speakers
- A. Addeo (Geneva, Switzerland)
3P - Notable variation of molecular testing in metastatic lung cancer in the Netherlands
Authors
- C. Epskamp-Kuijpers (Utrecht, Netherlands)
- M. Van den Heuvel (Nijmegen, Netherlands)
- L. Overbeek (Houten, Netherlands)
- A. Van Lindert (Utrecht, Netherlands)
- R. Damhuis (Utrecht, Netherlands)
- S. Willems (Utrecht, Netherlands)
Speakers
- C. Epskamp-Kuijpers (Utrecht, Netherlands)
48P - Education and lung cancer: A Mendelian randomisation study
Authors
- H. Zhou (Guangzhou, China)
- Y. Zhang (Guangzhou, China)
- J. Liu (Guangzhou, China)
- Y. Yang (Guangzhou, China)
- W. Fang (Guangzhou, China)
- S. Hong (Guangzhou, China)
- G. Chen (Guangzhou, China)
- S. Zhao (Guangzhou, China)
- Z. Zhang (Guangzhou, China)
- J. Shen (Guangzhou, China)
- W. Xian (Guangzhou, China)
- Y. Huang (Guangzhou, China)
- H. Zhao (Guangzhou, China)
- L. Zhang (Guangzhou, China)
Speakers
- H. Zhou (Guangzhou, China)
49P - A Mendelian randomization study of the effects of Crohn’s disease on lung cancer
Authors
- J. Liu (Guangzhou, China)
- H. Zhou (Guangzhou, China)
- Y. Zhang (Guangzhou, China)
- W. Fang (Guangzhou, China)
- Y. Yang (Guangzhou, China)
- S. Hong (Guangzhou, China)
- G. Chen (Guangzhou, China)
- S. Zhao (Guangzhou, China)
- J. Shen (Guangzhou, China)
- W. Xian (Guangzhou, China)
- Y. Huang (Guangzhou, China)
- H. Zhao (Guangzhou, China)
- L. Zhang (Guangzhou, China)
Speakers
- J. Liu (Guangzhou, China)
60P - Nomogram for patients with stage I small cell lung cancer: A competing risk analysis
Authors
- J. Liu (Guangzhou, China)
- H. Zhou (Guangzhou, China)
- Y. Zhang (Guangzhou, China)
- W. Fang (Guangzhou, China)
- Y. Yang (Guangzhou, China)
- S. Hong (Guangzhou, China)
- G. Chen (Guangzhou, China)
- S. Zhao (Guangzhou, China)
- X. Chen (Guangzhou, China)
- Z. Zhang (Guangzhou, China)
- W. Xian (Guangzhou, China)
- J. Shen (Guangzhou, China)
- Y. Huang (Guangzhou, China)
- H. Zhao (Guangzhou, China)
- L. Zhang (Guangzhou, China)
Speakers
- J. Liu (Guangzhou, China)
73P - Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries
Authors
- R. Damhuis (Utrecht, Netherlands)
- S. Senan (Amsterdam, Netherlands)
- A. Khakwani (Nottingham, United Kingdom)
- S. Harden (Cambridge, United Kingdom)
- A. Helland (Oslo, Norway)
- T. Strand (Oslo, Norway)
Speakers
- R. Damhuis (Utrecht, Netherlands)
22P - Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors
Authors
- D. Dumoulin (Barendrecht, Netherlands)
- P. De Goeje (Rotterdam, Netherlands)
- M. Poncin (Rotterdam, Netherlands)
- K. Bezemer (Rotterdam, Netherlands)
- H. Groen (Groningen, Netherlands)
- E. Smit (Amsterdam, Netherlands)
- A. Dingemans (Maastricht, Netherlands)
- A. Kunert (Rotterdam, Netherlands)
- R. Hendriks (Rotterdam, Netherlands)
- J. Aerts (Rotterdam, Noord Brabant, Netherlands)
Speakers
- D. Dumoulin (Barendrecht, Netherlands)